SCHEMBL5653666

SCHEMBL5653666

O=c1c2ccc3[nH]ccc3c2ccn1Cc1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
THRB P10828 1/20 0.48
DBH P09172 1/20 0.47
ALDH1A1 P00352 3/20 0.45
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TP53 P04637 2/20 0.40
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPK14 Q16539 1/20 0.39
BRD4 O60885 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 3/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38
FAAH O00519 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
TNIK Q9UKE5 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14515066 0.86 DHPS (0.46) MAPTDBHALDH1A1MEN1KMT2A
SCHEMBL6385918 0.75 MEN1 (0.46) MAPTDBHALDH1A1MEN1KMT2A
SCHEMBL5308841 0.74 MPO (0.44) MAPTTHRBDBHALDH1A1MEN1
SCHEMBL1893762 0.74 MAPT (0.51) MAPTTHRBDBHALDH1A1TP53
SCHEMBL1897110 0.73 PARP1 (0.56) MAPTTHRBALDH1A1TP53GAA
SCHEMBL5316613 0.73 MAPT (0.47) MAPTTHRBALDH1A1MEN1KMT2A
SCHEMBL12668470 0.71 MAPT (0.51) MAPTTHRBALDH1A1MEN1KMT2A
SCHEMBL5311352 0.70 MAPT (0.44) MAPTTHRBALDH1A1MEN1KMT2A
SCHEMBL5313862 0.69 HTR6 (0.45) MAPTTHRBALDH1A1MEN1KMT2A
SCHEMBL5183061 0.69 MAPT (0.55) MAPTTHRBALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007053353-A2 PYRROLO[2,3-F] AND [3,2-F]ISOQUINOLINONE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2007-05-10 WO disclosed
US-20070099912-A1 Pyrrolo[2,3-F] and [3,2-F]Isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2007-05-03 US disclosed
US-20070099912-A1 Pyrrolo[2,3-F] and [3,2-F]Isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2007-05-03 US disclosed
US-20070099912-A1 Pyrrolo[2,3-F] and [3,2-F]Isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099912-A1 Pyrrolo[2,3-F] and [3,2-F]Isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands HTR2C, HTR5A, HTR6 MAPT 1263/4885THRB 582/4885DBH 333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.